NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 09 11:26AM ET
1.09
Dollar change
+0.08
Percentage change
7.92
%
Index- P/E- EPS (ttm)-7.12 Insider Own0.84% Shs Outstand14.13M Perf Week5.83%
Market Cap15.40M Forward P/E- EPS next Y-1.64 Insider Trans0.00% Shs Float14.01M Perf Month42.45%
Income-21.76M PEG- EPS next Q-0.56 Inst Own3.89% Short Float3.32% Perf Quarter36.59%
Sales0.00M P/S- EPS this Y73.47% Inst Trans1.02% Short Ratio0.08 Perf Half Y-55.33%
Book/sh1.77 P/B0.62 EPS next Y2.49% ROA-78.93% Short Interest0.47M Perf Year-78.59%
Cash/sh0.30 P/C3.60 EPS next 5Y37.81% ROE-135.80% 52W Range0.40 - 5.29 Perf YTD-35.88%
Dividend Est.- P/FCF- EPS past 5Y26.36% ROI-343.43% 52W High-79.39% Beta1.64
Dividend TTM- Quick Ratio0.97 Sales past 5Y0.00% Gross Margin- 52W Low174.21% ATR (14)0.10
Dividend Ex-Date- Current Ratio0.97 EPS Y/Y TTM52.82% Oper. Margin- RSI (14)56.95 Volatility4.40% 9.66%
Employees17 Debt/Eq0.08 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price10.67
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q89.13% Payout- Rel Volume0.11 Prev Close1.01
Sales Surprise- EPS Surprise119.48% Sales Q/Q- EarningsMay 13 AMC Avg Volume5.68M Price1.09
SMA2010.45% SMA506.98% SMA200-43.33% Trades Volume218,209 Change7.92%
Date Action Analyst Rating Change Price Target Change
Feb-12-25Downgrade Maxim Group Buy → Hold
Jul-18-22Resumed Oppenheimer Outperform $14
May-07-25 09:00AM
May-06-25 09:00AM
May-05-25 08:45AM
Apr-29-25 08:35AM
Apr-17-25 08:30AM
08:41AM Loading…
Apr-02-25 08:41AM
05:51AM
Apr-01-25 09:55AM
08:30AM
Mar-26-25 12:00PM
Mar-25-25 03:00AM
01:38AM
Mar-24-25 10:50AM
07:05AM
Mar-19-25 08:05AM
08:45AM Loading…
Mar-11-25 08:45AM
Mar-10-25 08:45AM
Mar-06-25 08:30AM
Mar-03-25 08:30AM
Feb-25-25 12:35PM
Feb-13-25 01:19PM
01:05PM
09:25AM
Feb-12-25 10:25AM
Feb-11-25 08:40AM
Jan-27-25 08:30AM
Jan-08-25 08:30AM
08:30AM
Dec-11-24 08:00AM
Nov-18-24 08:15AM
08:15AM Loading…
Nov-14-24 08:15AM
Nov-12-24 10:59PM
08:00AM
Nov-11-24 11:19PM
07:05AM
Nov-05-24 09:00AM
Nov-04-24 08:30AM
Oct-18-24 08:57AM
Oct-17-24 08:40AM
Oct-09-24 05:02PM
Oct-07-24 08:30AM
Oct-04-24 09:00AM
Sep-23-24 08:00AM
Sep-16-24 08:30AM
Sep-09-24 08:15AM
Sep-03-24 09:15AM
Aug-26-24 08:30AM
Aug-19-24 04:05PM
Aug-16-24 08:00AM
Aug-14-24 08:05AM
Aug-05-24 09:05AM
Aug-01-24 08:30AM
Jul-10-24 08:30AM
Jun-17-24 08:00AM
Jun-14-24 08:00AM
Jun-12-24 09:00AM
Jun-10-24 08:00AM
Jun-05-24 08:55AM
May-16-24 08:32AM
06:22AM
May-15-24 08:38AM
May-14-24 03:00AM
May-13-24 07:30AM
May-10-24 09:52PM
May-09-24 08:30AM
May-08-24 08:45AM
May-07-24 08:55AM
May-02-24 09:00AM
May-01-24 08:50AM
Apr-25-24 09:45AM
Apr-18-24 08:30AM
Apr-10-24 08:30AM
Mar-28-24 10:45AM
Mar-27-24 09:25AM
09:05AM
Mar-26-24 08:36AM
Mar-25-24 07:30AM
Mar-22-24 08:52PM
05:31PM
04:05PM
Mar-20-24 07:30AM
Mar-19-24 04:30PM
Mar-12-24 09:05AM
Jan-24-24 08:50AM
Dec-20-23 09:16PM
Dec-11-23 08:50AM
Nov-14-23 01:46PM
10:29AM
Nov-13-23 08:05AM
08:00AM
Nov-07-23 08:45AM
Nov-06-23 08:35AM
Oct-24-23 07:45AM
Oct-18-23 10:00AM
Oct-11-23 09:05AM
Oct-02-23 08:40AM
Sep-22-23 07:58AM
Sep-21-23 08:50AM
Sep-18-23 08:40AM
Sep-14-23 08:35AM
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.